Pharmaceutical companies and anti-doping officials

Today numerous drug manufacturers are ready to cooperate with anti-doping officials in their war on application of prohibited preparations in sports. It sounds strange but this is the reality. In fact, if you look at the fate of EPO, you can comprehend why drug manufacturers agree to support efforts of anti-doping agencies. EPO is actually an effectual remedy for treatment of anemia. Numerous persons with anemia that have taken EPO have been treated. But what do you think while hearing about this drug? Almost any individual associates this remedy just with doping in sports. This medicine has been abused by Lance Armstrong that has cheated the whole world. So, EPO is associated just with cheating, disgrace, etc. Looking at this condition, drug manufacturers try to “defend” their preparations from the similar fate. That’s why they collaborate with anti-doping officers.
However some pharmaceutical companies started to collaborate with anti-doping officers earlier, sometimes there were some problems between them. Anti-doping officers criticized several drug manufacturers for their links to doping.
Today relations between anti-doping officials and drug manufacturers are better. Pharmaceutical companies share detailed information about new preparations with anti-doping officers. It is precious information for development of detection tests for these medications. While anti-doping officials find out how medications are manufactured, how they pass into body, how they work in the body, they can elaborate more effective tests for these preparations.
For example, the drug manufacturer Roche that elaborated the drug CERA helped anti-doping officers to develop a detection test for it. Later other drug manufacturers followed the example of Roche. The pharmaceutical company GlaxoSmithKline went so far, as it sponsored an anti-doping lab during the 2012 Olympics.
While relations between anti-doping officers and big pharmaceutical companies become stronger, smaller drug manufacturers started to collaborate with anti-doping agencies too. While previously pharmaceutical companies haven’t wanted to discuss about their links to anti-doping agencies publicly, now they don’t fear to announce about this condition.